HALO
Halozyme Therapeutics Inc
110.80$
+1.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +22.4% | -24.2% | +14.1% | +88.8% | +197.4% | -83.7% | +14.0% | -27.4% | +135.7% | -5.5% | -31.3% | +18.1% | +16.1% | -52.8% | +117.8% | +18.3% | +86.3% | -26.9% | +53.3% | -15.1% | -11.9% | +15.0% | +29.9% | +37.2% | -13.1% | -10.7% | +36.3% | -2.3% | +6.5% | -14.8% | +18.1% | +25.4% | +2.7% | -11.1% | +23.0% | +8.8% | +27.5% | -16.6% | +27.7% | – | |
| – | -12.4% | -5.7% | +3.2% | +7.0% | -10.1% | -59.2% | -72.6% | -25.1% | +798.1% | -17.3% | -59.6% | +1,089.8% | -25.3% | -65.3% | -0.8% | -3.0% | +371.8% | -30.7% | +26.3% | -19.2% | +16.1% | -26.2% | +113.2% | +39.4% | -11.0% | -16.5% | +42.4% | +9.5% | -4.6% | -11.9% | +24.5% | -13.8% | -14.9% | +57.3% | -3.1% | -13.8% | +42.6% | +0.6% | -0.1% | – | |
| – | +36.5% | -29.0% | +17.9% | +113.4% | +228.7% | -84.7% | +23.5% | -27.5% | +119.1% | -4.2% | -28.7% | -35.9% | +54.7% | -47.1% | +152.9% | +20.7% | +59.7% | -25.8% | +60.2% | -14.3% | -17.3% | +26.0% | +16.8% | +36.5% | -13.8% | -8.9% | +34.6% | -5.7% | +10.3% | -15.7% | +16.2% | +38.3% | +6.4% | -22.4% | +31.7% | +14.3% | +24.7% | -20.2% | +35.1% | – | |
| – | +22.1% | -10.7% | +3.8% | -11.3% | +21.7% | -8.2% | +5.6% | -11.3% | +3.1% | -14.5% | +8.2% | -10.2% | +48.1% | -77.5% | -11.9% | -13.5% | -4.7% | +22.1% | -10.4% | +5.2% | +19.1% | +17.3% | +30.6% | +7.9% | +35.1% | -20.3% | +9.7% | -12.2% | +23.2% | -10.4% | +10.1% | -12.3% | +10.7% | -27.6% | +18.5% | -1.7% | +84.9% | -19.9% | +8.2% | – | |
| – | +5.4% | +3.2% | +3.9% | +1.7% | +10.8% | -8.2% | +5.9% | +3.6% | +21.3% | -0.1% | -3.7% | +3.7% | +33.1% | -47.2% | -13.1% | +6.6% | +7.9% | -12.5% | +11.4% | +6.9% | +4.6% | +0.4% | +315.5% | -40.0% | +9.5% | -1.0% | +4.3% | -9.4% | +6.6% | -6.6% | +1.6% | +15.5% | +2.4% | +0.3% | -1.8% | +10.8% | +67.1% | -24.9% | -1.5% | – | |
| – | +17.8% | -7.5% | +3.8% | -8.0% | +18.6% | -8.2% | +5.6% | -7.4% | +8.5% | -9.8% | +3.9% | -5.5% | +42.5% | -67.0% | -12.6% | -2.4% | -8.4% | +12.7% | +1.6% | +6.2% | +10.3% | +7.6% | +228.4% | -7.1% | -17.2% | +12.8% | +4.6% | -4.7% | +5.2% | -29.3% | +4.6% | +36.5% | +3.9% | -29.0% | +3.5% | +37.1% | +63.1% | -14.6% | +1.1% | – | |
| – | – | – | – | – | +1,459.1% | -118.8% | – | – | – | – | -571.2% | – | – | – | – | +36.4% | +92.6% | -34.6% | +83.4% | -18.8% | -25.2% | +33.8% | -55.0% | +144.5% | -10.5% | -27.8% | +75.6% | -6.5% | +14.4% | -5.4% | +22.7% | +39.2% | +7.5% | -19.4% | +43.0% | +7.6% | +10.5% | -23.3% | +55.9% | – | |
| – | +6.6% | -2.7% | +1.7% | 0.0% | -1.4% | -4.2% | -8.8% | -10.1% | -12.4% | -14.6% | -18.5% | -20.5% | +79.5% | +43.3% | -6.4% | -0.3% | +0.9% | -61.0% | -10.8% | +0.1% | +17.2% | -14.4% | +76.5% | +142.1% | -39.2% | -0.6% | -1.1% | +0.2% | +15.9% | -13.7% | +0.4% | +0.0% | +0.4% | -0.3% | -2.9% | -2.2% | +14.3% | +12.2% | +1.5% | – | |
| – | – | – | – | – | +3,551.3% | -122.4% | – | – | – | – | -903.5% | – | – | – | – | +40.2% | +102.0% | -61.7% | +225.8% | -19.0% | -26.0% | +35.8% | -59.7% | +145.6% | -4.0% | -26.2% | +78.3% | +9.2% | -0.6% | -5.1% | +22.6% | +40.3% | +7.9% | -19.3% | +42.5% | +6.8% | -146.1% | – | +58.0% | – | |
| – | -132.9% | – | -14.3% | +222.2% | -501.9% | – | -82.4% | +12,887.9% | -92.6% | -93.1% | -22.7% | -23.5% | -584.6% | – | +427.3% | +8.6% | +34.9% | +124.7% | -69.6% | -245,756.9% | – | – | -48.8% | +64.8% | +8.4% | -3.6% | +45.8% | +8.3% | -20.8% | +21.7% | +27.6% | +14.9% | +46.4% | -37.5% | +54.6% | +9.9% | -6.8% | -25.7% | +81.6% | – | |
| – | – | – | – | – | +4,406.4% | -122.2% | – | – | – | – | -914.3% | – | – | – | – | +40.2% | +102.1% | -61.9% | +227.9% | +136.8% | -69.2% | -10.0% | -62.3% | +171.7% | -6.4% | -31.3% | +88.7% | +9.5% | +4.3% | -10.0% | +21.4% | +46.9% | +0.0% | -13.8% | +39.9% | +6.1% | -180.8% | – | +53.2% | – | |
| – | – | – | – | – | +1,374.7% | -117.0% | – | – | – | +662.2% | -377.9% | – | – | – | +27,934.5% | +32.8% | +88.0% | -61.1% | +205.5% | -18.6% | -24.7% | +33.5% | -40.7% | +142.0% | -25.3% | -6.3% | +53.1% | +9.3% | -1.7% | -5.0% | +18.1% | +33.2% | +6.9% | -16.9% | +36.1% | +6.0% | -128.4% | – | +47.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.